6-Chlor-7,8-dimethyl-symm.-triazolo<4,3-b>pyridazin | 23069-70-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并哒嗪类
• 英文名称: 6-Chlor-7,8-dimethyl-symm.-triazolo<4,3-b>pyridazin
• 英文别名: 6-chloro-7,8-dimethyl-[1,2,4]triazolo[4,3-b]pyridazine；6-chloro-7,8-dimethyl-s-triazolo[4,3-b]pyridazine；6-Chloro-7,8-dimethyl-[1,2,4]triazolo[4,3-b]pyridazine
• CAS: 23069-70-7
• 化学式: C₇H₇ClN₄
• 分子量: 182.612
• InChiKey: YQICVQYDFXLZIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  43.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-Chlor-7,8-dimethyl-symm.-triazolo<4,3-b>pyridazin 在 tris-(dibenzylideneacetone)dipalladium(0) 、 caesium carbonate 、 N,N-二异丙基乙胺 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 1,4-二氧六环 、 N-甲基吡咯烷酮 为溶剂， 反应 36.0h， 生成 6-(7,8-dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N-(2-fluorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine
  参考文献：
  名称：

  [EN] 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS
  [FR] DÉRIVÉS DE 7,8-DIHYDRO-5H-1,6-NAPHTYRIDINE UTILISÉS EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS DU RÉCEPTEUR MUSCARINIQUE DE L'ACÉTYLCHOLINE M4 POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES ET PSYCHIATRIQUES

  摘要：

  The present invention relates to 6-([1,2,4]triazolo[4,3-b]pyridazin-6- yl)-7,8-dihydro-5H-1,6-naphthyridine derivatives, 6-(imidazo[1,2- b]pyridazin-6-yl)-7,8-dihydro-5H-1,6-naphthyridine derivatives or 6- (imidazo[1,5-b]pyridazin-6-yl)-7,8-dihydro-5H-1,6-naphthyridine derivatives of formula (I) The present compounds are positive allosteric modulators of the muscarinic acetylcholine receptor M4 (mAChR M4) for use in treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction. An exemplary compound is e.g. compound 1 Data on the activity of exemplary compounds in an mAChR M4 cell- based assay is provided.

  公开号：

  WO2023064584A1
• 作为产物：
  描述：

  3-chloro-6-hydrazinyl-4,5-dimethylpyridazine 在 甲酸 作用下， 生成 6-Chlor-7,8-dimethyl-symm.-triazolo<4,3-b>pyridazin
  参考文献：
  名称：

  3,6,7,8-Substituted-s-triazolo[4,3-b]pyridazines as bronchodilators

  摘要：

  3,6,7,8-取代-s-三唑吡啶化合物，如7,8-二甲基-6-吗啉基-3-甲基-s-三唑[4,3-b]吡啶或7,8-二甲基-6-(1-吡咯烷基)-3-(异丙基)-s-三唑-[4,3-b]吡啶，通过羧酸与取代的3-叠氮基-6-卤代吡啶的反应制备，然后通过所得的6-卤代三唑吡啶与相应的碱的反应制备。这些化合物具有支气管扩张剂的药理活性。

  公开号：

  US04526890A1

文献信息

• 3,6,7,8-Substituted-s-triazolo(4,3-b)-pyridazines, their preparation and compositions comprising them
  申请人：THE DOW CHEMICAL COMPANY

  公开号：EP0029130A1

  公开（公告）日：1981-05-27

  3,6,7,8-substituted-s-triazolo-pyridazine compounds of the formula wherein R3 represents hydrogen or loweralkyl, R6 represents amino, loweralkylamino, diloweralkylamino, heterocyclic amino or lower alkyl substituted heterocyclic amino, wherein the heterocyclic moiety forms a 5, 6 or 7 membered ring, having one or two ring nitrogen atoms and zero or one ring sulfur or oxygen atom; T7 represents loweralkyl; R8 represents hydrogen or loweralkyl; or R7 and R8 taken together represent polymethylene of 3 or 4 methylene units or polymethylene substituted by lower alkyl, or methano or ethano bridges; and their pharmacologically acceptable salts are made by reacting a carboxylic acid with a substituted 3-hydrazino-6-halo-pyridazine and then reacting the resulting 6-halotriazolopyridazine with a corresponding base. The compounds have pharmacological activity as bronchodilators.

  式中，R3代表氢或低碳基，R6代表氨基，低碳基氨基，二低碳基氨基，杂环氨基或低碳基取代的杂环氨基，其中杂环基形成一个5、6或7个成员的环，有一个或两个环氮原子和零或一个环硫或氧原子；T7代表低碳基；R8代表氢或低碳基；或R7和R8一起代表3或4个亚甲基单元的聚甲基或低碳基取代的聚甲基，或甲烷或乙烷桥；它们的药物学可接受盐是由羧酸与取代的3-肼基-6-卤代吡啶嗪反应，然后将得到的6-卤代三唑吡啶与相应的碱反应制得的。这些化合物具有支气管扩张剂的药理活性。
• US4526890A
  申请人：——

  公开号：US4526890A

  公开（公告）日：1985-07-02
• 3,6,7,8-Substituted-s-triazolo[4,3-b]pyridazines as bronchodilators
  申请人：The Dow Chemical Company

  公开号：US04526890A1

  公开（公告）日：1985-07-02

  3,6,7,8-Substituted-s-triazolo-pyridazine compounds such as 7,8-dimethyl-6-morpholino-3-methyl-s-triazolo[4,3-b]pyridazine or 7,8-dimethyl-6-(1-pyrrolidinyl)-3-(isopropyl)-s-triazolo-[4,3-b]pyridazine are prepared by the reaction of a carboxylic acid with a substituted 3-hydrazino-6-halo-pyridazine followed by the reaction of the resulting 6-halotriazolopyridazine with a corresponding base. The compounds have pharmacological activity as bronchodilators.

  3,6,7,8-取代-s-三唑吡啶化合物，如7,8-二甲基-6-吗啉基-3-甲基-s-三唑[4,3-b]吡啶或7,8-二甲基-6-(1-吡咯烷基)-3-(异丙基)-s-三唑-[4,3-b]吡啶，通过羧酸与取代的3-叠氮基-6-卤代吡啶的反应制备，然后通过所得的6-卤代三唑吡啶与相应的碱的反应制备。这些化合物具有支气管扩张剂的药理活性。
• [EN] 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS<br/>[FR] DÉRIVÉS DE 7,8-DIHYDRO-5H-1,6-NAPHTYRIDINE UTILISÉS EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS DU RÉCEPTEUR MUSCARINIQUE DE L'ACÉTYLCHOLINE M4 POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES ET PSYCHIATRIQUES
  申请人：[en]VANDERBILT UNIVERSITY

  公开号：WO2023064584A1

  公开（公告）日：2023-04-20

  The present invention relates to 6-([1,2,4]triazolo[4,3-b]pyridazin-6- yl)-7,8-dihydro-5H-1,6-naphthyridine derivatives, 6-(imidazo[1,2- b]pyridazin-6-yl)-7,8-dihydro-5H-1,6-naphthyridine derivatives or 6- (imidazo[1,5-b]pyridazin-6-yl)-7,8-dihydro-5H-1,6-naphthyridine derivatives of formula (I) The present compounds are positive allosteric modulators of the muscarinic acetylcholine receptor M4 (mAChR M4) for use in treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction. An exemplary compound is e.g. compound 1 Data on the activity of exemplary compounds in an mAChR M4 cell- based assay is provided.